Pharma IT ManCo ApS: Financial statements 2023
CVR: 43329782
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Pharma IT ManCo ApS (CVR 43329782) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -19,905 and a net result of DKK 46,889,001. Equity in the 2023 report amounted to DKK 77,531,645. The solvency ratio was 92.5%.
- Revenue
- DKK 0
- Gross Profit
- DKK -19,905
- Profit/Loss
- DKK 46,889,001
- Equity
- DKK 77,531,645
- Total Assets
- DKK 83,839,579
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Pharma IT ManCo ApS has published its interim report for the period June 15, 2022 – December 31, 2022.
As of June 29, 2023, REDMARK, GODKENDT REVISIONSPARTNERSELSKAB has been appointed auditor of Pharma IT ManCo ApS.
About Pharma IT ManCo ApS
Pharma IT ManCo ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2022. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jakob Juul Rasmussen, Peter-Emil Iversen and Søren Winkel. The company's owners include PEI Holding ApS, JaJR Holding ApS and SqWi Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -38,610 and a net result of DKK -9,326,249 compared with DKK 27,506,401 the year before. Equity in the 2025 report amounted to DKK 27,708,473.